Novo Nordisk’s Liraglutide, a once-daily human GLP-1 analogue, that underwent phase-III study, has proved sustained improvements in blood sugar control in patients with early type-2 diabetes. High Blood Sugar Related Articles
The Coronary Health Improvement Program, or CHIP, will begin at Lebanon Samaritan Community Hospital on Sept. 26. The class is aimed at teaching healthy lifestyle choices that can help lower blood pressure, blood sugar, and increase overall health. High Blood Sugar Related Articles
Liraglutide, a new drug in the same class as Byetta, cuts blood sugar and lowers weight in a year-long study of people with early type 2 diabetes. High Blood Sugar Related Articles
The idea that consuming sugar will lead to symptoms resulting from changes in blood glucose level is not new. Two versions of this theory are common. One supposes that the increase in blood glucose following sugar intake will be felt as a high or sugar rush. High Blood Sugar Related Articles
Comments on this entry are closed.